Middletown, DE -- (SBWIRE) -- 10/31/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Neurocrine Biosciences, Inc (NASDAQ:NBIX), Rovi Corporation (NASDAQ:ROVI), MELA Sciences Inc (NASDAQ:MELA), NutriSystem Inc (NASDAQ:NTRI)
Neurocrine Biosciences, Inc (NASDAQ:NBIX) the stock opened the session at $10.65 but then moved to $9.83. At that price, the stock showed a negative performance of -7.85%. Neurocrine Biosciences, Inc. (Neurocrine) discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. The Company’s product candidates address some of the pharmaceutical markets including endometriosis, stress-related disorders, pain, diabetes,
Will NBIX Get Buyers Even After The Recent Rally? Find Out Here
Rovi Corporation (NASDAQ:ROVI) opened the session at $19.45 and closed the session at $18.97. The stock showed a negative performance of -2.3% in previous trading session. Rovi Corporation is focused on powering the discovery and enjoyment of digital entertainment by providing a set of integrated solutions that are embedded in its customers' products and services and used by end consumers to simplify and guide their interaction with digital entertainment. The Company's offerings include content discovery,
Has ROVI Found The Bottom And Ready To Gain Momentum? Find Out Here
MELA Sciences Inc (NASDAQ:MELA) opened the session at $0.82 and closed the session at $0.720. The stock showed a negative performance of -14.29% in previous trading session. Traded with volume of 1.22 million shares in the prior session and the average volume of the stock remained 355,112.00 shares. The beta of the stock remained 0.63. MELA Sciences, Inc. is a medical device company focused on the commercialization of its product, MelaFind, and the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care (in the doctor's office) instrument to aid in the detection of melanoma. MelaFind, features a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions.
Why Should Investors Buy MELA After the Recent Fall? Just Go Here and Find Out
NutriSystem Inc (NASDAQ:NTRI) the stock decreased -0.83% and finished the session at $17.98. Traded with volume of 1.19 million shares in the prior session and the average volume of the stock remained 482,481.00 shares. The beta of the stock remained 0.44. Nutrisystem, Inc. (Nutrisystem) is a provider of a weight management system. The Company’s customers purchase monthly food packages containing a 28-day supply of breakfasts, lunches, dinners and desserts, which they supplement with dairy, fruit, salad, vegetables and low-glycemic carbohydrate items.
Will NTRI Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)